New ‘cutting edge’ hemophilia treatment is a victory for patients, Tulane doctor says

Research scientist with gloves holding blood sample on glass in laboratory. Biology doctor analyzing plasma dna for medical discovery in pharmaceutical industry. Science equipment on desk

A new treatment that helps people with hemophilia A maintain higher levels of a crucial blood clotting factor with fewer treatments is a victory for patients, according to a new editorial in The New England Journal of Medicine this week by Dr. Cindy Leissinger, director of the Louisiana Center for Bleeding and Clotting Disorders at Tulane University School of Medicine.

COVID vaccines and first boosters provided protection to pregnant women during Omicron surge

Previous article

Treatment to boost white blood cells may benefit patients with glioblastoma

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News